Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer
PHASE2
Background:
Immunotherapy is a powerful tool in the fight against cancer. ...
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
PHASE1
Background:
Endometrial cancer (EC) of the uterus is becoming more common ...
Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
PHASE2
This phase II/III Lung-MAP trial studies how well immunotherapy treatment w...
Status
Active Not Recruiting
Location
Veterans Administration Medical Center - Birmingham